Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals

Zürcher Kantonalbank, along with its subsidiaries, has submitted Form 8.3 to the Irish Takeover Panel. This form pertains to their interests in Avadel Pharmaceuticals plc's securities. As of November 17, 2025, Zürcher Kantonalbank holds an interest of 1.17% in Avadel's ordinary shares, totaling 1,143,058 shares.

The disclosure does not report any dealings or open positions in cash-settled or stock-settled derivatives. Additionally, several transactions involving ordinary shares as title transfer collateral were noted, including receiving 311,236 shares and delivering 53,484 and 124,529 shares, respectively.

There are no disclosed indemnity arrangements, nor any agreements related to options or derivatives. The submission does not include a Supplemental Form 8, indicating no additional disclosures.